This website uses cookies to improve your user experience.
By using the site, you agree to our use of cookies.
Click here for more information about how we use cookies.
Applicants should have a PhD, MD or equivalent with a specialization in immunotherapy or gene therapy. The specific techniques include but not limited to viral vector system design, primary human cell, animal models, immunoassays (Flow, ELISPOT, ELISA, etc.). Successful candidate should have strong analytical, communication and writing skills to perform data collection and analyses, draft publications and apply to competitive national finding. Previous experience with viral vectors will be considered as additional plus. Comprehensive knowledge in flow cytometry highly desirable.
The major project for this position will be focused on exosome protected viral-based vaccine interaction with immune cell, role of cross-presentation pathway in vaccine function, use of cancer vaccine in small and large (canine) animal models. Additionally, postdoc initiated projects highly encouraged. Lab is funded by NIHR01, Minnesota Partnership for Biotechnology and Medical Genomics Award, Paint Town Pink for Brest Cancer Award. Salary commensurate with experience and according to NIH guide for postdoctoral compensation.
To learn more visit: https://www.hi.umn.edu/portfolio-items/george-aslanidi/. Please send CV to gaslanid@umn.edu.
Application deadline: 31 Jan 2021